Invention Grant
- Patent Title: Starter kit for basal insulin titration
-
Application No.: US16327502Application Date: 2017-08-24
-
Publication No.: US11282598B2Publication Date: 2022-03-22
- Inventor: Brad Warren Van Orden , Jakob Oest Wielandt , Thomas Dedenroth Miller , Tinna Bjoerk Aradottir , Pete Brockmeier , Henrik Bengtsson
- Applicant: Novo Nordisk A/S
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Wesley Nicolas
- Priority: EP16188931 20160915
- International Application: PCT/EP2017/071332 WO 20170824
- International Announcement: WO2018/037080 WO 20180301
- Main IPC: G16H20/17
- IPC: G16H20/17 ; G16H50/50 ; G16H10/60 ; G16H50/30 ; G16H50/20 ; G16H40/63 ; A61M5/168 ; A61M5/315 ; H04H60/82 ; C12Q1/54

Abstract:
Systems and methods for treating a subject are provided. A first dataset comprising timestamped autonomous glucose measurements of the subject over a first time course is obtained. A second dataset, associated with a standing insulin regimen for the subject over the first time course and comprising insulin medicament records, is also obtained. Each record comprises a timestamped injection event including an amount and type of insulin medicament injected into the subject by an insulin pen. The first and second datasets serve to calculate a glycaemic risk measure and an insulin sensitivity factor of the subject during the first time course, which are used to obtain a basal titration schedule and a fasting blood glucose profile model over a subsequent second time course for the subject. The model predicts the fasting blood glucose level of the subject based upon amounts of basal insulin medicament injected into the subject.
Public/Granted literature
- US20190180857A1 STARTER KIT FOR BASAL INSULIN TITRATION Public/Granted day:2019-06-13
Information query